Orion Infusions (DHA:ORIONINFU) EBIT per Share : BDT4.11 (TTM As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Orion Infusions EBIT per Share?

Orion Infusions's EBIT per Share for the three months ended in Mar. 2024 was BDT0.91. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was BDT4.11.

During the past 12 months, the average EBIT per Share Growth Rate of Orion Infusions was -13.60% per year. During the past 3 years, the average EBIT per Share Growth Rate was 0.50% per year. During the past 5 years, the average EBIT per Share Growth Rate was 0.40% per year. During the past 10 years, the average EBIT per Share Growth Rate was 1.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Orion Infusions's EBIT per Share or its related term are showing as below:

DHA:ORIONINFU' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -6.2 Med: 2.75 Max: 16.8
Current: 0.5

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Orion Infusions was 16.80% per year. The lowest was -6.20% per year. And the median was 2.75% per year.

DHA:ORIONINFU's 3-Year EBIT Growth Rate is ranked worse than
62.41% of 854 companies
in the Drug Manufacturers industry
Industry Median: 7.7 vs DHA:ORIONINFU: 0.50

Orion Infusions's EBIT for the three months ended in Mar. 2024 was BDT18.4 Mil.

Orion Infusions EBIT per Share Historical Data

The historical data trend for Orion Infusions's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Infusions EBIT per Share Chart

Orion Infusions Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

EBIT per Share

Get a 7-Day Free Trial

3.94

3.83

3.98

4.66

3.92

Orion Infusions Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial															0.81	1.00	1.23	0.97	0.91

Orion Infusions EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Orion Infusions's EBIT per Share for the fiscal year that ended in Jun. 2023 is calculated as

	EBIT per Share		(A: Jun. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	79.813	/	20.360
=	3.92

Orion Infusions's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	18.425	/	20.170
=	0.91

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT4.11

Orion Infusions (DHA:ORIONINFU) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Orion Infusions EBIT per Share Related Terms

Thank you for viewing the detailed overview of Orion Infusions's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Orion Infusions (DHA:ORIONINFU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Infusions Ltd (DHA:ORIONINFU) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Tejgaon Industrial Area, No. 153-154, Dhaka, BGD, 1208

Website

https://www.orioninfusion.com

Orion Infusions Ltd is a pharmaceutical company. It produces various types of intravenous fluids, rehydration solutions, electrolyte solutions, antimicrobial products, and other pharmaceutical products in Bangladesh. The products of the company include Dextrolac, Dextropac, Dextrosal, Dianak, Electro dex, fructose, Hartman, Intralipid, Manisol, Maprocin, Nidazyl, Orlev, Ortac, Plasmasol, Proliv, and Salpac. In addition, the company is also involved in activities related to cosmetics and toiletries, infrastructure development, real estate and construction, power, agro products, hospitality, textiles and garments, and aviation management sectors. Geographically, it operates in Bangladesh.

Orion Infusions (DHA:ORIONINFU) Headlines

No Headlines